Morten Mau‐Sørensen
- Genetics top 2%
- Glioma Diagnosis and Treatment 13
- Oncology top 2%
- Lung Cancer Research Studies 15
- Peptidase Inhibition and Analysis 10
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 19
- Hematology top 5%
-
- Nuclear Structure and Function 18
- Cancer therapeutics and mechanisms 17
-
- Gastric Cancer Management and Outcomes 11
-
- Neuroendocrine Tumor Research Advances 11
- Co-authors
- Ulrik LassenHans Skovgaard PoulsenBenedikte HasselbalchEnriqueta FelipMie GrunnetMichael KauffmanMichael KosteljanetzSharon Shacham
- Cited by
- GeneticsOncologyCancer Research
- Journals
- Journal of Clinical Oncology (29 papers)SHILAP Revista de lepidopterología (1 paper)Blood (4 papers)
- Partner nations
- DenmarkUnited StatesNetherlands
In The Last Decade
Morten Mau‐Sørensen
125 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 111
- Genetics 570
- Oncology 1.2k
- Cancer Research 541
- Hematology 258
- Pathology and Forensic Medicine 310
Countries citing papers authored by Morten Mau‐Sørensen
This map shows the geographic impact of Morten Mau‐Sørensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Mau‐Sørensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Mau‐Sørensen more than expected).
Fields of papers citing papers by Morten Mau‐Sørensen
This network shows the impact of papers produced by Morten Mau‐Sørensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Mau‐Sørensen. The network helps show where Morten Mau‐Sørensen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Morten Mau‐Sørensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2021 | 40 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 18 | |
| 5 | 2020 | 21 | |
| 6 | 2019 | 22 | |
| 7 | 2018 | 59 | |
| 8 | 2017 | 112 | |
| 9 | PHARMACOKINETICS AND SAFETY OF OLAPARIB IN PATIENTS WITH ADVANCED SOLID TUMORS AND HEPATIC OR RENAL IMPAIRMENT | 2017 | 1 |
| 10 | 2015 | 42 | |
| 11 | 2015 | 47 | |
| 12 | 2014 | 32 | |
| 13 | 2014 | 43 | |
| 14 | 2013 | 46 | |
| 15 | 2012 | 47 | |
| 16 | 2012 | 37 | |
| 17 | [Gender differences among medical students in the approach to simulation]. | 2011 | 8 |
| 18 | 2010 | 74 | |
| 19 | 2008 | 84 | |
| 20 | 2005 | 6 |
About Morten Mau‐Sørensen
Morten Mau‐Sørensen is a scholar working on Oncology, Cancer Research and Genetics, having authored 130 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (19 papers), Nuclear Structure and Function (18 papers), Cancer therapeutics and mechanisms (17 papers), Lung Cancer Research Studies (15 papers), Glioma Diagnosis and Treatment (13 papers), Gastric Cancer Management and Outcomes (11 papers), Neuroendocrine Tumor Research Advances (11 papers) and Peptidase Inhibition and Analysis (10 papers). The work is most often cited by research in Genetics (570 citations), Oncology (1.2k citations) and Cancer Research (541 citations). Morten Mau‐Sørensen has collaborated with scholars based in Denmark, United States and Netherlands. Frequent co-authors include Ulrik Lassen, Hans Skovgaard Poulsen, Benedikte Hasselbalch, Enriqueta Felip, Mie Grunnet, Michael Kauffman, Michael Kosteljanetz, Sharon Shacham, Tami Rashal and Nashat Gabrail. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.